Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Headlines have been challenging in 2025. Companies are under attack publicly and privately for policies viewed as “too progressive” or “woke.” The reality, however, is that most companies have ...

Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...

MUMBAI, India, Jan. 13, 2026 /PRNewswire/ -- True social impact is not created in silos, it emerges when health, education, livelihoods and the environment are addressed as part of a connected ...

Ashley St. Clair, a conservative influencer, had just put her baby down for the night Sunday when she got a text from a friend that turned her weekend into a nightmare: People on X were using the ...

This past year, a computer scientist named Tuhin Chakrabarty tried to coax artificial intelligence into producing great writing. Chakrabarty, who had recently completed a Ph.D. at Columbia University, ...

Disney announced it will make a $1 billion equity investment in OpenAI. The companies said Sora and ChatGPT Image users will also be able to make AI content with Disney's copyrighted characters. Some ...

Eeny, meeny, miny, mo, catch a tiger by the toe – so the rhyme goes. But even children know that counting-out rhymes like this are no help at making a truly random choice. Perhaps you remember when ...

Splunk for Windows has a high-severity flaw that lets local users escalate privileges through misconfigured file permissions. Learn how to fix it. Image generated by Google’s Nano Banana A newly ...